Literature DB >> 25234821

Myocardial drug distribution generated from local epicardial application: potential impact of cardiac capillary perfusion in a swine model using epinephrine.

Mikhail Y Maslov1, Elazer R Edelman2, Matthew J Pezone3, Abraham E Wei4, Matthew G Wakim5, Michael R Murray6, Hisashi Tsukada7, Iraklis S Gerogiannis8, Adam Groothuis9, Mark A Lovich10.   

Abstract

Prior studies in small mammals have shown that local epicardial application of inotropic compounds drives myocardial contractility without systemic side effects. Myocardial capillary blood flow, however, may be more significant in larger species than in small animals. We hypothesized that bulk perfusion in capillary beds of the large mammalian heart not only enhances drug distribution after local release, but also clears more drug from the tissue target than in small animals. Epicardial (EC) drug releasing systems were used to apply epinephrine to the anterior surface of the left heart of swine in either point-sourced or distributed configurations. Following local application or intravenous (IV) infusion at the same dose rates, hemodynamic responses, epinephrine levels in the coronary sinus and systemic circulation, and drug deposition across the ventricular wall, around the circumference and down the axis, were measured. EC delivery via point-source release generated transmural epinephrine gradients directly beneath the site of application extending into the middle third of the myocardial thickness. Gradients in drug deposition were also observed down the length of the heart and around the circumference toward the lateral wall, but not the interventricular septum. These gradients extended further than might be predicted from simple diffusion. The circumferential distribution following local epinephrine delivery from a distributed source to the entire anterior wall drove drug toward the inferior wall, further than with point-source release, but again, not to the septum. This augmented drug distribution away from the release source, down the axis of the left ventricle, and selectively toward the left heart follows the direction of capillary perfusion away from the anterior descending and circumflex arteries, suggesting a role for the coronary circulation in determining local drug deposition and clearance. The dominant role of the coronary vasculature is further suggested by the elevated drug levels in the coronary sinus effluent. Indeed, plasma levels, hemodynamic responses, and myocardial deposition remote from the point of release were similar following local EC or IV delivery. Therefore, the coronary vasculature shapes the pharmacokinetics of local myocardial delivery of small catecholamine drugs in large animal models. Optimal design of epicardial drug delivery systems must consider the underlying bulk capillary perfusion currents within the tissue to deliver drug to tissue targets and may favor therapeutic molecules with better potential retention in myocardial tissue.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contractility; Epicardial drug delivery; Inotrope; Myocardial drug distribution; Systemic vascular resistance

Mesh:

Substances:

Year:  2014        PMID: 25234821      PMCID: PMC4252373          DOI: 10.1016/j.jconrel.2014.09.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  54 in total

1.  Distribution of amiodarone in heart tissues following intrapericardial administration.

Authors:  J T Darsinos; J N Karli; E C Samouilidou; B Krumbholz; A C Pistevos; G M Levis
Journal:  Int J Clin Pharmacol Ther       Date:  1999-06       Impact factor: 1.366

2.  Intrapericardial delivery enhances cardiac effects of sotalol and atenolol.

Authors:  Thomas J van Brakel; J J Rob Hermans; Ben J Janssen; Helma van Essen; Nicole Botterhuis; Jos F M Smits; Jos G Maessen
Journal:  J Cardiovasc Pharmacol       Date:  2004-07       Impact factor: 3.105

3.  Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia.

Authors:  J J Lopez; E R Edelman; A Stamler; M G Hibberd; P Prasad; K A Thomas; J DiSalvo; R P Caputo; J P Carrozza; P S Douglas; F W Sellke; M Simons
Journal:  Am J Physiol       Date:  1998-03

4.  Atrium-targeted drug delivery through an amiodarone-eluting bilayered patch.

Authors:  Robert W Bolderman; Peter Bruin; J J Rob Hermans; Mark J Boerakker; Aylvin A Dias; Frederik H van der Veen; Jos G Maessen
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-03       Impact factor: 5.209

5.  Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype.

Authors:  Hong Lu; Giselle C Meléndez; Scott P Levick; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-09       Impact factor: 4.733

6.  Spectrophotometric determination of some catecholamine drugs using metaperiodate.

Authors:  M E el-Kommos; F A Mohamed; A S Khedr
Journal:  J Assoc Off Anal Chem       Date:  1990 Jul-Aug

7.  Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

Authors:  E R Edelman; D H Adams; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.

Authors:  C Rogers; M J Karnovsky; E R Edelman
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

9.  High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery.

Authors:  Mikhail Y Maslov; Elazer R Edelman; Abraham E Wei; Matthew J Pezone; Mark A Lovich
Journal:  J Control Release       Date:  2013-07-18       Impact factor: 9.776

10.  Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart.

Authors:  Kapil Kumar; Khanh Nguyen; Sergio Waxman; Bruce D Nearing; Gregory A Wellenius; Susan X Zhao; Richard L Verrier
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

View more
  3 in total

1.  [Establishment of a rabbit model of small diameter vascular graft replacement].

Authors:  Jia-Qing Zhang; Kun-Tang Chen; Fu-Wei Zhang; Shao-Bin Li; Yuan-Zhou Wu; Jing Feng; Wu-Jun Wang; Yu-Sheng Yan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

2.  Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium.

Authors:  Ravi K Ghanta; Samira Aghlara-Fotovat; Aarthi Pugazenthi; Christopher T Ryan; Vivek P Singh; Megumi Mathison; Maria I Jarvis; Sudip Mukherjee; Andrea Hernandez; Omid Veiseh
Journal:  Biomater Sci       Date:  2020-09-15       Impact factor: 6.843

3.  A four-compartment PBPK heart model accounting for cardiac metabolism - model development and application.

Authors:  Zofia Tylutki; Sebastian Polak
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.